网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
立体定向伽玛射线治疗后肝癌患者血清端粒酶逆转录酶 mRNA水平研究
作者:简明 罗俊卿 刘阳 
单位:武警湖南总队医院医务处
关键词:肝细胞癌 立体定向伽玛射线治疗术 端粒酶逆转录酶 实时定量PCR  
分类号:
出版年·卷·期(页码):2014·42·第九期(998-1001)
摘要:

目的:探讨肝癌患者立体定向伽玛射线治疗术后血清端粒酶逆转录酶 mRNA水平变化。 方法:应用实时荧光定量PCR技术测量35例肝细胞癌患者立体定向伽玛射线术前和术后1d,3d,9d,15d和30d的血清端粒酶逆转录酶 mRNA水平。结果:立体定向伽玛射线术后hTERT mRNA水平短暂升高后迅速下降,15d后明显低于术前,差异有统计学意义(p<0.001)。 结论 血清hTERT mRNA水平检测有助于肝细胞癌患者伽玛刀治疗的疗效观察。

Objective To investigate the serum human telomerase reverse transcriptase(hTERT) mRNA level of hepatocellular carcinoma(HCC) patients treated by stereotactic gamma-ray body radiation therapy ( γ-SBRT ). Methods The serum hTERT mRNA levels of 35 HCC cases were measured in γ-SBRT preoperative and postoperative 1d, 3d, 9d, 15d and 30d by real-time quantitative PCR. Results The Serum hTERT mRNA level was declined rapidly after a transient increase and lower than preoperative level significantly(p<0.001). Conclusions The detection of Serum hTERT mRNA level was conducive to treatment efficacy observation ofγ-SBRT postoperative HCC patients.

参考文献:
服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 752114 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541